Somatostatin Analogs Market
Somatostatin Analogs Market - Global Industry Assessment & Forecast
#
Pages:
220
Base Year:
2023
Nov - 2024
Format:
Report Code:
VMR-3148
Segments Covered
By
Type Octreotide, Lanreotide, Pasireotide
-
By
Application Acromegaly, Neuroendocrine Tumors (NETs), Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 7.01 Billion |
 Revenue 2032:
|
USD 13.21 Billion |
 Revenue CAGR
(2024 - 2032): |
7.3% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Somatostatin Analogs Market Segment Analysis
- Somatostatin Analogs Type Outlook (Revenue, USD Million, 2018 - 2030)
- Octreotide
- Lanreotide
- Pasireotide
- Somatostatin Analogs Application Outlook (Revenue, USD Million, 2018 - 2030)
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
-
North America Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- U.S.
- U.S. Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- U.S. Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- U.S. Somatostatin Analogs Market, by Type
- Canada
- Canada Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Canada Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Canada Somatostatin Analogs Market, by Type
-
Mexico
- Mexico Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Mexico Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Mexico Somatostatin Analogs Market, by Type
-
North America Somatostatin Analogs Market, by Type
- Europe
-
Europe Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
-
Europe Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- U. K.
- U.K. Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- U.K. Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- U.K. Somatostatin Analogs Market, by Type
- France
- France Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- France Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- France Somatostatin Analogs Market, by Type
-
Germany
- Germany Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Germany Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Germany Somatostatin Analogs Market, by Type
-
Italy
- Italy Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Italy Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Italy Somatostatin Analogs Market, by Type
-
Spain
- Spain Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Spain Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Spain Somatostatin Analogs Market, by Type
-
Rest of Europe
- Rest of Europe Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Rest of Europe Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Rest of Europe Somatostatin Analogs Market, by Type
-
Europe Somatostatin Analogs Market, by Type
- Asia Pacific
-
Asia Pacific Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
-
Asia Pacific Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- China
- China Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- China Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- China Somatostatin Analogs Market, by Type
- Japan
- Japan Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Japan Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Japan Somatostatin Analogs Market, by Type
-
Germany
- Germany Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Germany Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Germany Somatostatin Analogs Market, by Type
-
India
- India Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- India Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- India Somatostatin Analogs Market, by Type
-
South Korea
- South Korea Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- South Korea Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- South Korea Somatostatin Analogs Market, by Type
-
South East Asia
- South East Asia Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- South East Asia Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- South East Asia Somatostatin Analogs Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Rest of Asia Pacific Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Rest of Asia Pacific Somatostatin Analogs Market, by Type
-
Asia Pacific Somatostatin Analogs Market, by Type
- Latin America
-
Latin America Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
-
Latin America Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Brazil
- Brazil Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Brazil Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Brazil Somatostatin Analogs Market, by Type
- Argentina
- Argentina Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Argentina Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Argentina Somatostatin Analogs Market, by Type
-
Rest of Latin America
- Rest of Latin America Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Rest of Latin America Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Rest of Latin America Somatostatin Analogs Market, by Type
-
Latin America Somatostatin Analogs Market, by Type
- Middle East & Africa
-
Middle East & Africa Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
-
Middle East & Africa Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- GCC Countries
- GCC Countries Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- GCC Countries Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- GCC Countries Somatostatin Analogs Market, by Type
- South Africa
- South Africa Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- South Africa Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- South Africa Somatostatin Analogs Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Somatostatin Analogs Market, by Type
- Octreotide
- Lanreotide
- Pasireotide
- Rest of Middle East & Africa Somatostatin Analogs Market, by Application
- Acromegaly
- Neuroendocrine Tumors (NETs)
- Others
- Rest of Middle East & Africa Somatostatin Analogs Market, by Type
-
Middle East & Africa Somatostatin Analogs Market, by Type
- North America
Vantage Market
Research | 15-Nov-2024
FAQ
Frequently Asked Question
What is the global demand for Somatostatin Analogs in terms of revenue?
-
The global Somatostatin Analogs valued at USD 7.01 Billion in 2023 and is expected to reach USD 13.21 Billion in 2032 growing at a CAGR of 7.3%.
Which are the prominent players in the market?
-
The prominent players in the market are Novartis AG, Ipsen Pharma, Fresenius Kabi, Peptron, Pfizer Inc., Teva Pharmaceuticals Inc., Other Companies.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.3% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Somatostatin Analogs include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Somatostatin Analogs in 2023.
